The Recall Desk
Agency classClass IIIOur severity:LowFDA (Drugs)·D-1267-2020·Announced 2020-05-20

ChapStick Total Hydration Moisture Tint Recalled for Packaging Separation

Glaxosmithkline is recalling ChapStick Total Hydration Moisture Tint Very Berry due to observed separation in the secondary packaging.

The agency’s classification

FDA (Drugs): Class III

Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 1/5 (Low).

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a packaging defect (separation) rather than a product contamination or labeling error affecting safety.

Plain-English summary

Glaxosmithkline Consumer Healthcare Holdings is recalling ChapStick Total Hydration Moisture Tint Very Berry (Zinc Oxide). The recall involves 288 packages of the product, which is marketed by Pfizer and distributed nationwide.

The reason for the recall is observed separation in the secondary packaging, specifically between the blister and the backer card. The affected lots are 9346AA and 9347AA.

Consumers with this product should stop using it and contact the manufacturer for instructions on how to return or dispose of the item.

The recalled product

Product
CHAPSTICK TOTAL HYDRATION MOISTURE TINT VERY BERRY (ZINC OXIDE)
Brand
CHAPSTICK TOTAL HYDRATION MOISTURE TINT VERY BERRY
Manufacturer
Glaxosmithkline Consumer Healthcare Holdings
Category
Drug — OTC Topical
Hazard
Affected units
288

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 9346AA
  • 9347AA

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 3 recalled by Glaxosmithkline Consumer Healthcare Holdings under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →

Related recalls

Same manufacturer · Glaxosmithkline Consumer Healthcare Holdings

See all →

Same hazard · packaging defect

See all →

Similar recalls